Esensor Warfarin Sensitivity and XT-8 Instrument
Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System. 510(k) K073720, from Osmetech Molecular Diagnostics (Pasadena, CA). Product code ODW, class 2.
As of Nov 20, 2026, K073720 is an FDA 510(k) held by Osmetech Molecular Diagnostics, substantially equivalent on Jul 17, 2008 after 199 days, with no recalls tied to it in FDA's recall database.
- Review time: 199 days
- Recalls: 0
- Cited as a predicate by: 6 devices
The eSensor® Warfarin Sensitivity Test is an in vitro diagnostic for the detection and genotyping of the *2 and *3 alleles of the cytochrome P450 (CYP450) 2C9 gene locus and the Vitamin K epoxide reductase C1 (VKORC1) gene promoter polymorphism (-1639G>A) from genomic DNA extracted from whole blood samples preserved with EDTA, as an aid in the identification of patients at risk for increased…
- TruDiagnosis SystemK183530 · Akonni Biosystems, Inc. · May 24, 2019
- ePlex InstrumentK163652 · Genmark Diagnostics, Incorporated · Jun 9, 2017
- Esensor Respiratory Viral PanelK113731 · Clinical Micro Sensors, Inc. · Sep 10, 2012
- Esensor Warfarin Sensitivity Saliva TestK110786 · GenMark Diagnostics, Inc. · Dec 2, 2011
- Esenor Fii-Fv-Mthfr Genotyping Test, Esenor Fii-Fv Genotyping Test, Esenor Fii GenotypingK093974 · Osmetech Molecular Diagnostics · Apr 22, 2010
- Esensor CF Genotyping Testm Esensor System, Esensor Cystic Fibrosis Genotyping Test, Esensor Instrument, Models XT-8K090901 · Osmetech Molecular Diagnostics · Jul 6, 2009
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 31, 2007
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3360
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files